Agenus | AGEN - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.67B 140M 2026-06
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Celldex Therapeutics USD 724.93M 265.71M 2026-06
CSL USD 11.85B 1000K 2025-12
Eli Lilly USD 64.67B 9.84B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Incyte USD 6.03B 542.31M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 59.77B 601M 2026-06
Jiangsu Hengrui CNY 52.04B 553.82M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck EUR 13.77B 393M 2026-06
Merck USD 36.68B 1.66B 2026-06
Northwest Biotherapeutics USD 6.2M 996K 2026-03
Novartis USD 27.35B 744M 2026-06
Novavax USD 771.1M 79.72M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 574.78M 52.6M 2026-06